The Value of Metatron Hunter 4025 in Gastric Cancer Assessment

Gastric cancer remains one of the most serious medical problems in many countries worldwide. Most researchers working on the diagnosis and treatment of gastric cancer conclude that timely and early diagnosis can facilitate cancer treatment and improve patient outcomes.

For decades, radiology and endoscopy have remained the primary methods for diagnosing gastric cancer. A major drawback of these methods is their inability to obtain images of the thick layers of the stomach wall, thus limiting data on the extent of tumor invasion into the stomach wall—the stage of the tumor process—preoperatively. Attempts to stage gastric tumors were first made when survey methods such as computed tomography (CT), transabdominal ultrasound (US), and more recently, the NLS survey, entered clinical practice. In today's medicine, the NLS study may become an important method for diagnosing celiac disease due to its simplicity, accessibility, and non-invasiveness. However, given that this survey method has been used in medical practice since the late 1990s, the number of published studies on the potential of NLS in diagnosing solid organs remains insufficient.

A fairly well-defined NLS (Neural Light Surgery) method for gastric examination has been developed, and some signs of NLS in cancerous, benign, and malignant gastric ulcers have been described. Attempts to establish staging of gastric cancer using NLS surveys have resulted in a fairly high diagnostic accuracy (75.8%), primarily due to the diagnosis of early stages of the tumor process. According to some authors, the NLS of the Metatron Hunter 4025 offers some undisputed opportunities for staging gastric tumors primarily located in the distal region of the stomach.

According to most researchers, until recently, the NLS of the Metatron Hunter 4025 was primarily used as a method to determine the extent of cancer spread, to identify extragastric metastases and malignant invasions; in other words, the NLS survey method is even capable of diagnosing gastric tumors in the presence of disease.